Opioid Peptides: Simultaneous δ Agonism and μ Antagonism in Somatostatin Analogues
- 1 January 1997
- Vol. 18 (1) , 93-100
- https://doi.org/10.1016/s0196-9781(96)00242-2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A topographical model of μ‐opioid and brain somatostatin receptor selective ligands NMR and molecular dynamics studiesInternational Journal of Peptide and Protein Research, 1995
- Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 miceGeneral Pharmacology: The Vascular System, 1992
- Topographically designed analogs of [cyclic] [D-Pen2,D-Pen5]enkephalinJournal of Medicinal Chemistry, 1991
- Conformation of two somatostatin analogues in aqueous solutionEuropean Journal of Biochemistry, 1989
- Design of a new class of superpotent cyclic .alpha.-melanotropins based on quenched dynamic simulationsJournal of the American Chemical Society, 1989
- Design and synthesis of somatostatin analogs with topographical properties that lead to highly potent and specific .mu. opioid receptor antagonists with greatly reduced binding at somatostatin receptorsJournal of Medicinal Chemistry, 1988
- Design and synthesis of conformationally constrained somatostatin analogs with high potency and specificity for .mu. opioid receptorsJournal of Medicinal Chemistry, 1986
- PCNONLIN and NONLIN84: Software for the Statistical Analysis of Nonlinear ModelsThe American Statistician, 1986
- Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimersJournal of Medicinal Chemistry, 1985
- Conformational restrictions of biologically active peptides via amino acid side chain groupsLife Sciences, 1982